Steven D Mathews

Statistics

Publications

Citations

640

H-Index

Active since

2007

Affiliations

Pfizer (United States)(Current)

Steven D Mathews is an author at Pfizer (United States) specializing in rheumatoid arthritis therapy, pharmacotherapy, and rheumatoid arthritis pharmacotherapy.

Publications per year

2007–2017

Publications

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

Medicine, Pharmacology, Pharmacotherapy +12

The immunogenicity, safety, and efficacy of etanercept liquid administered once weekly in patients with rheumatoid arthritis.

Dore RK, Steven D Mathews, Joy Schechtman et al. · PubMed · 2007 · 144 citations

Medicine, Clinical Sciences, Pharmacotherapy +16

1–2 of 2